Tags : Out-Licenses

GSK Out Licenses its Tuberculosis Vaccine (M72/AS01E ) to Bill

Shots: GSK has licensed its M72/AS01E to the Gates MRI for further development and potential use of vaccine therapy in low-income countries with high TB burdens Under the agreement, the GATES MRI will lead the development program and will be responsible to sponsor future clinical studies while GSK will provide the AS01 adjuvant for the […]Read More

Amgen Out-Licenses its AMG 714 (PRO-015) Candidate to Provention to

Shots: Amgen to make $20M investment in Provention and also has option to license AMG-714 (after completion of P-IIb), if exercised will pay $150M as upfront plus milestones and royalties to Provention Provention to fund and conduct the P-IIb trial for PRO-015 (AMG 714) and holds commercialization rights (if not exercised by Amgen) while giving […]Read More